Thromb Haemost 1985; 53(02): 282-284
DOI: 10.1055/s-0038-1661294
International Committee Communications
Schattauer GmbH Stuttgart

Nomenclature of Secreted Platelet Proteins – Report of the Working Party on Secreted Platelet Proteins of the Subcommittee on Platelets

Karen L Kaplan
1   The Department of Medicine, Columbia University College of Physicians & Surgeons, NY, NY, USA
,
Stefan Niewiarowski
2   The Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, PA, USA
› Author Affiliations
Further Information

Publication History

Received 27 June 1984

Accepted 18 January 1985

Publication Date:
18 July 2018 (online)

Summary

Standard nomenclature for a number of secreted platelet proteins was agreed upon by The Working Party on Secreted Platelet Proteins of the Subcommittee on Platelets. Platelet factor 4 will continue to be used for the molecule with high heparin affinity, subunit molecular weight of 7780, and the described amino acid sequence. β-Thromboglobulin will be used to designate β-Thromboglobulin (81 amino acids/subunit, β-mobility on cellulose-acetate electrophoresis, pI 7), low-affinity platelet factor 4 (85 amino acids/subunit, y-mobility on cellulose-acetate electrophoresis, pI 8), and platelet basic protein (94 amino acids/ subunit, pI 10) when these are measured immunologically in plasma, but that thromboglobulin with a superscript designation of the pI should be used when assays are conducted on samples after isoelectric focusing, and a subscript amino-terminal amino acid can be added when a purified protein is described. Thrombospondin will continue to be the designation for the high molecular weight trimer that has previously been called thrombospondin or glycoprotein G. Platelet derived growth factor will be used for the group of closely related proteins of molecular weight about 30,000 and isoelectric point about 10.

 
  • References

  • 1 Deuel TF, Keim PS, Fanner M, Heinrikson RL. The complete amino acid sequence of human platelet factor 4. Proc Natl Acad Sci USA 1981; 74: 2256-2258
  • 2 Hermodsen M, Schmer G, Kurachi K. Isolation, crystallization and primary amino acid sequence of human platelet factor 4. J Biol Chem 1977; 252: 6276-6279
  • 3 Morgan FJ, Begg GS, Chesterman CN. Primary structure of human platelet factor 4. Thromb Haemostas 1977; 38: 231 (Abstr.)
  • 4 Walz DA, Wu VY, deLamo R, Dene H, McCoy LE. Primary structure of human platelet factor 4. Thromb Res 1977; 11: 893-898
  • 5 Kaser-Glanzmann R, Jakabova M, Luscher EF. Isolation and some properties of the heparin-neutralizing factor (PF4) released from human blood platelets. Experientia 1972; 28: 1221-1223
  • 6 Moore S, Pepper DS, Cash JD. Platelet anti-heparin activity: The isolation and characterization of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane- bound anti-heparin activity. Biochim Biophys Acta 1975; 379: 370-384
  • 7 Ginsberg MM, Hopkins R, Sigrist P, Painter R. Purification of heparin neutralizing protein from rabbit platelets and its homology with human platelet factor 4. J Biol Chem 1979; 254: 12365-12371
  • 8 Ciaglowski RE, Snow JW, Walz DE. Bovine platelet antiheparin protein: platelet factor 4. Ann NY Acad Sci 1981; 370: 668-679
  • 9 Rucinski B, Poggi A, James P, Holt JC, Niewiarowski S. Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins. Blood 1983; 61: 1072-1080
  • 10 Moore S, Pepper DS, Cash JD. The isolation and characterization of a platelet- specific β-globulin (β-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta 1975; 379: 360-369
  • 11 Moore S, Pepper DS. In Platelets in Biology and Pathology. Gordon JL. (Ed) Elsevier; North Holland, Amsterdam: 1976. p 293
  • 12 Begg GS, Pepper DS, Chesterman CN, Morgan FJ. Complete covalent structure of human p-thromboglobulin. Biochemistry 1978; 17: 1739-1744
  • 13 Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ. Antiheparin proteins secreted by human platelets: purification, characterization, and radioimmunoassay. Blood 1979; 53: 47-62
  • 14 Niewiarowski S, Walz DA, James P, Rucinski B, Kueppers F. Identification and separation of secreted platelet proteins by isoelectric focusing. Evidence that low-affinity platelet factor 4 is converted to β-thromboglobulin by limited proteolysis Blood 1980; 55: 453-456
  • 15 Holt JC, Harris ME, Lange E, Rucinski B, Henschen A, Niewiarowski S. Platelet basic protein (PBP) is the precursor of low affinity platelet factor 4 (LA- PF4) and p thromboglobin (PTG). Fed Proc 1982; 41: 528
  • 16 Paul D, Niewiarowski S, Vanma KG, Rucinski B, Rucker S, Lange E. Human platelet basic protein associated with antiheparin and antigenic activities. Purification and partial characterisation Proc Natl Acad Sci (USA) 1980; 77: 5914-5918
  • 17 Hagen I. Effects of thrombin on washed human platelets: changes in subcellular fractions. Biochim Biophys Acta 1975; 392: 242-254
  • 18 Hagen I, Olsen T, Solum NO. Studies on subcellular fractions of human platelets by the lactoperoxidase - iodination technique. Biochim Biophys Acta 1976; 455: 214-225
  • 19 Lawler JW, Chao FC, Fang PH. Observation of a high molecular weight platelet protein released by thrombin. Thromb Haemostas 1977; 37: 355-357
  • 20 Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253: 8609-8616
  • 21 Mosher DF, Jaffe EA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 1982; 93: 343-348
  • 22 McPherson J, Sage IT, Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin J Biol Chem 1981; 256: 11330-11336
  • 23 Phillips DR, Jennings LK, Prasanna HR. Ca++ mediated association of glycoprotein G (thrombin sensitive protein, thrombospondin) with human platelets. J Biol Chem 1980; 155: 11629-11632
  • 24 Margossian SS, Lawler JW, Slayter H. Physical characterization of platelet thrombospondin. J Biol Chem 1981; 256: 7495-7500
  • 25 Lawler J, Chao FC, Cohen CM. Evidence for calcium-sensitive structure in platelet thrombospondin: Isolation and partial characterization of thrombospondin in the presence of calcium. J Biol Chem 1982; 257: 12257-12265
  • 26 Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68: 240-243
  • 27 Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 1972; 247: 2723-2731
  • 28 Heldin C-H, Westermark B, Wasteson A. Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci 1979; 76: 3722-3726
  • 29 Antoniades HN, Scher CD, Stiles CD. Purification of human platelet-derived growth factor. Proc Natl Acad Sci USA 1979; 76: 1809-1813
  • 30 Raines EW, Ross RPlatelet-derived. Platelet-derived growth factor: I. High yield purification and evidence for multiple forms. J Biol Chem 1982; 257: 5154-5160
  • 31 Witte LD, Kaplan KL, Nossel HL, Lages BA, Weiss HJ, Goodman DeWS. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 1978; 42: 402-409
  • 32 Habenicht Jr A, Glomset JA, Ross R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 1980; 255: 5234-5240
  • 33 Witte LD, Cornicelli JA, Miller RW, Goodman DeWS. Effects of platelet derived and endothelial cell-derived growth factors on the low density lipoprotein receptor pathway in cultured human fibroblasts. J Biol Chem 1982; 257: 5392-5401
  • 34 Deuel TF, Huang SS, Huang JS. PDGF stimulated protein kinase activity in human smooth muscle cells. Thromb Haemostas 1983; 50: 71 (Abstr.)
  • 35 Williams LT, Frackelton Jr AR. Platelet-derived growth factor activation of tyrosine-kinase in vascular smooth muscle: detection by monoclonal antibody to phosphotyrosine. Circulation 1983; (Suppl. 68) (SuppIII): 73
  • 36 Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982; 69: 1046-1049
  • 37 Senior RM, Griffin GL, Huang JS, Walz DA, Deuel TF. Chemotactic activity of alpha-granule proteins for fibroblasts. J Cell Biol 1983; 96: 382-385
  • 38 Grotendorst GR, Seppa HE, Kleinman HK, Martin GR. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci 1981; 78: 3669-3672
  • 39 Seppa H, Grotendorst GR, Seppa S, Schiffmann E, Martin GR. Platelet- derived growth factor is chemotactic for fibroblasts. J Cell Biol 1982; 92: 584-588
  • 40 Antoniades HN, Hunkapiller MW. Human platelet-derived growth factor: Amino-terminal amino acid sequence. Science 1983; 220: 963-965
  • 41 Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C, Huang JS, Deuel F. Platelet-derived growth factor is structurally related to the putative transforming protein p28 of simian sarcoma virus. Nature 1983; 304: 35-39
  • 42 Heldin CH, Wasteson A, Westermark B. Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells. Exp Cell Res 1977; 109: 429-437
  • 43 Kepner N, Creasy G, Lipton A. Platelets as a source of cell-proliferatory activity in platelets: A Multidisciplinary Approach. de Gaetano G, Garattini S. (Eds) Raven Press; New York: 1978. p 205
  • 44 Assoian RK, Komoriya A, Meyers CA, Miller DM, Spora MB. Transforming growth factor-B in human platelets. J Biol Chem 1983; 258: 7155-7160
  • 45 Clemmons DR, Isley WL, Brown MT. Dialyzable factor in human serum of platelet origin stimulates endothelial cell replication and growth. Proc Natl Acad Sci 1983; 80: 1641-1645
  • 46 Castor CW, Ritchie JC, Scott MF, Whitney SL. Connective tissue activation. XI Stimulation of glycosaminoglycans and DNA formation by a platelet factor Arthritis Rheum 1977; 20: 859-868
  • 47 Castor CW, Ritchie JC, Williams CH, Scott ME, Whitney SL, Meyers SL, Sloan TB, Anderson BE. Connective tissue activation XIV Composition and action of human platelet autocoid mediator. Arthritis Rheum 1979; 22: 260-272
  • 48 Castor CW, Miller JW, Walz DA. Structural and biological characteristics of connective tissue activating peptide, a major human platelet-derived growth factor. Proc Natl Acad Sci USA 1983; 80: 765-769
  • 49 Niewiarowski S, Paul D. Platelet granule proteins with mitogenic and antiheparin activity. In Platelets in Biology and Pathology 2. Gordon IL. (Ed) Elsevier; North Holland: 1981. pp 91-106